Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
27-30 April, 2026
Not Confirmed
Not Confirmed
27-30 April, 2026
Bioprocess Internation...Bioprocess International Europe
Not Confirmed
Not Confirmed
27-30 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
27-30 April, 2026
Industry Trade Show
Not Confirmed
27-30 April, 2026
Bioprocess Internation...Bioprocess International Europe
Industry Trade Show
Not Confirmed
27-30 April, 2026
Digital content

07 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/07/2775232/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-Presents-Compelling-New-Data-for-a-Novel-Treatment-for-Malignant-Glioma-at-38th-Annual-Meeting-of-the-Society-for-Immunotherapy-o.html

02 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/02/2772458/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-to-Present-at-the-38th-Annual-Meeting-of-the-Society-for-Immunotherapy-of-Cancer.html

10 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/11/10/2553395/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-Announces-Key-Scientific-Data-to-be-Presented-at-the-37th-Annual-Meeting-and-Exposition-of-the-Society-for-Immunotherapy-of-Cance.html

18 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/18/2536566/0/en/Scopus-Biopharma-Completes-Recapitalization-Designed-To-Enhance-Shareholder-Value.html

05 May 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/05/05/2436835/0/en/Scopus-BioPharma-Announces-Biotechnology-Industry-Leader-Rejoins-Board-of-Directors.html

22 Mar 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/03/23/2408185/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-to-Present-at-the-3rd-Annual-STING-TLR-Targeting-Therapies-Summit.html
ABOUT THIS PAGE